Literature DB >> 1495948

The relationships among tumor-infiltrating lymphocytes, histopathologic findings, and long-term clinical follow-up in renal cell carcinoma.

P C Kolbeck1, F F Kaveggia, S L Johansson, M T Grune, R J Taylor.   

Abstract

The relative abundance of tumor-infiltrating mononuclear cells (TIM) was retrospectively evaluated by immunohistology in nephrectomy specimens from 24 cases of human renal cell carcinoma (RCC). The extent of T-lymphocyte (T-cell) and B-lymphocyte (B-cell) infiltration of the tumors was graded semiquantitatively (0 to 4) in each case. Results of this analysis were correlated with clinical evidence of recurrent RCC, histologic evidence of venous invasion, tumor necrosis, and histologic cell type. Clinical follow-up demonstrated the presence of recurrent tumors in four of the 24 cases (17%), and these cases correlated with higher stage and pathologic grade tumors, as well as significantly increased TIM. Venous invasional and tumor necrosis correlated directly with tumor size, pathologic grade, and extent of TIM. Venous invasion was also associated with advanced stage. The group of cases with mixed or granular histologic cell type was associated with advanced stage, high pathologic grade, and increased T-cell infiltration compared to the clear-cell group of tumors. Overall, the pathologic grade demonstrated the highest correlation coefficients with clinical and TNM stage, but also correlated directly with the extent of T-cell infiltration of the tumor. These results confirm previous findings demonstrating a correlation in RCC between increased T-cell infiltration and both high clinical stage and pathologic grade. In addition, increased T-cell infiltration was found to correlate with tumor recurrence, indicating that such infiltration, along with high pathologic grade, is another indicator of poor prognosis in RCC.

Entities:  

Mesh:

Year:  1992        PMID: 1495948

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  14 in total

Review 1.  Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.

Authors:  Shona Hendry; Roberto Salgado; Thomas Gevaert; Prudence A Russell; Tom John; Bibhusal Thapa; Michael Christie; Koen van de Vijver; M V Estrada; Paula I Gonzalez-Ericsson; Melinda Sanders; Benjamin Solomon; Cinzia Solinas; Gert G G M Van den Eynden; Yves Allory; Matthias Preusser; Johannes Hainfellner; Giancarlo Pruneri; Andrea Vingiani; Sandra Demaria; Fraser Symmans; Paolo Nuciforo; Laura Comerma; E A Thompson; Sunil Lakhani; Seong-Rim Kim; Stuart Schnitt; Cecile Colpaert; Christos Sotiriou; Stefan J Scherer; Michail Ignatiadis; Sunil Badve; Robert H Pierce; Giuseppe Viale; Nicolas Sirtaine; Frederique Penault-Llorca; Tomohagu Sugie; Susan Fineberg; Soonmyung Paik; Ashok Srinivasan; Andrea Richardson; Yihong Wang; Ewa Chmielik; Jane Brock; Douglas B Johnson; Justin Balko; Stephan Wienert; Veerle Bossuyt; Stefan Michiels; Nils Ternes; Nicole Burchardi; Stephen J Luen; Peter Savas; Frederick Klauschen; Peter H Watson; Brad H Nelson; Carmen Criscitiello; Sandra O'Toole; Denis Larsimont; Roland de Wind; Giuseppe Curigliano; Fabrice André; Magali Lacroix-Triki; Mark van de Vijver; Federico Rojo; Giuseppe Floris; Shahinaz Bedri; Joseph Sparano; David Rimm; Torsten Nielsen; Zuzana Kos; Stephen Hewitt; Baljit Singh; Gelareh Farshid; Sibylle Loibl; Kimberly H Allison; Nadine Tung; Sylvia Adams; Karen Willard-Gallo; Hugo M Horlings; Leena Gandhi; Andre Moreira; Fred Hirsch; Maria V Dieci; Maria Urbanowicz; Iva Brcic; Konstanty Korski; Fabien Gaire; Hartmut Koeppen; Amy Lo; Jennifer Giltnane; Marlon C Rebelatto; Keith E Steele; Jiping Zha; Kenneth Emancipator; Jonathan W Juco; Carsten Denkert; Jorge Reis-Filho; Sherene Loi; Stephen B Fox
Journal:  Adv Anat Pathol       Date:  2017-11       Impact factor: 3.875

2.  Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions.

Authors:  M R Hussein; D A H Elsers; S A Fadel; A-E M Omar
Journal:  J Clin Pathol       Date:  2006-03       Impact factor: 3.411

Review 3.  Are cellular adhesion molecules involved in the metastasis of breast cancer?

Authors:  M Maemura; R B Dickson
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

4.  Dysfunctional DC subsets in RCC patients: ex vivo correction to yield an effective anti-cancer vaccine.

Authors:  M Gigante; A Blasi; A Loverre; V Mancini; M Battaglia; F P Selvaggi; E Maiorano; A Napoli; G Castellano; W J Storkus; L Gesualdo; E Ranieri
Journal:  Mol Immunol       Date:  2008-11-28       Impact factor: 4.407

5.  Predicting survival in patients with metastatic kidney cancer by gene-expression profiling in the primary tumor.

Authors:  James R Vasselli; Joanna H Shih; Shuba R Iyengar; Jodi Maranchie; Joseph Riss; Robert Worrell; Carlos Torres-Cabala; Ray Tabios; Andra Mariotti; Robert Stearman; Maria Merino; McClellan M Walther; Richard Simon; Richard D Klausner; W Marston Linehan
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

Review 6.  The possible role of stromal cell stimulation in worsening the prognosis of a subset of patients with breast cancer.

Authors:  T H Stewart; S C Tsai
Journal:  Clin Exp Metastasis       Date:  1993-07       Impact factor: 5.150

7.  T lymphocytes, CD68-positive cells and vascularisation in thyroid carcinomas.

Authors:  G Herrmann; P M Schumm-Draeger; C Müller; E Atai; B Wenzel; T Fabian; K H Usadel; K Hübner
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

Review 8.  Immune checkpoint blockade in renal cell carcinoma.

Authors:  Phillip M Rappold; Andrew W Silagy; Ritesh R Kotecha; Ari A Hakimi
Journal:  J Surg Oncol       Date:  2021-03       Impact factor: 3.454

9.  Clinical and pathological implications of concurrent autoimmune thyroid disorders and papillary thyroid cancer.

Authors:  L L Cunha; R C Ferreira; M A Marcello; J Vassallo; L S Ward
Journal:  J Thyroid Res       Date:  2011-02-17

10.  Prognostic significance of CD45RO+ memory T cells in renal cell carcinoma.

Authors:  K Hotta; M Sho; K Fujimoto; K Shimada; I Yamato; S Anai; N Konishi; Y Hirao; K Nonomura; Y Nakajima
Journal:  Br J Cancer       Date:  2011-09-20       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.